United States · FDA National Drug Code directory
Levothyroxine sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-6602_d79c0046-2c71-47a4-9b06-3ffe57e4243e
- Product NDC
- 50090-6602
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201125
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 112 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET in 1 BOTTLE (50090-6602-0) · 50090-6602-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →